fda sees safety issue with merck hepatitis drug
u.s. drug reviewers highlighted safety issues with an experimental merck &amp; co hepatitis drug, including anemia and reports of psychiatric problems, in documents released on monday.
http://feeds.reuters.com/~r/reuters/healthnews/~3/tco9ovjnkhe/us-merck-hepatitis-idustre73o2o020110425
10481
25 Apr 2011 18:02:48
reuters
health